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An E3-like Factor that Promotes SUMO Conjugation
to the Yeast Septins
latory protein IB by being attached at its major
ubiquitylation site (Desterro et al., 1998).
S. cerevisiae SUMO was first isolated as a dosage
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SUMO is conjugated to many different S. cerevisiae pro-
teins, most of which are unknown, and the pattern of
conjugates changes during the cell cycle and under dif-
Summary
ferent growth conditions (Li and Hochstrasser, 1999).
S. cerevisiae cells incapable of SUMO conjugation are
Covalent attachment of the ubiquitin-related protein
inviable, and conditional mutants arrest in the cell cycle
SUMO to other proteins participates in many pro- in G2/M, with fully replicated DNA but an undivided nu-cesses including signal transduction, transcriptional cleus (Li and Hochstrasser, 1999; Seufert et al., 1995).
regulation, and growth control. We report the charac- The most abundant SUMO conjugates in G2/M-terization of Siz1 as an E3-like factor in the SUMO arrested S. cerevisiae cells are members of the septin
pathway. Siz1 is required for SUMO attachment to the family of cytoskeletal proteins (Johnson and Blobel,
S. cerevisiae septins in vivo and strongly stimulates 1999; Takahashi et al., 1999). Septins are the central
septin sumoylation in vitro. Siz1 and the related protein components of a belt of 10 nm filaments encircling the
Siz2 promote SUMO conjugation to different sub- S. cerevisiae bud neck and are required for normal bud
strates at different stages of the cell cycle and, to- growth and for cytokinesis (Longtine et al., 1996). Sep-
gether, are required for most SUMO conjugation in tins are present at the bud neck throughout the cell
yeast. Siz1, Siz2, and the PIAS (protein inhibitor of cycle: a septin-containing ring forms in the mother cell
activated STAT) proteins form a conserved family de- during G1, and as the bud emerges, the ring extends
fined by an unusual RING-related motif. Our results into the bud, forming a continuous hourglass-shaped
suggest that this family functions by promoting SUMO structure. Yeast express five septins during vegetative
conjugation to specific substrates. growth: Cdc3, Cdc10, Cdc11, Cdc12, and Sep7/Shs1.
The soluble form of the septins is a heteromultimer with
an approximate stoichiometry of two each of the Cdc3,Introduction
Cdc10, and Cdc12 polypeptides and one Cdc11 poly-
peptide (Frazier et al., 1998). Sep7 is not tightly associ-SUMO is a conserved ubiquitin-related protein that func-
ated. Purified septins assemble into linear filaments intions by being covalently attached to other proteins as
vitro, and the present model for the structure of thea posttranslational modification. Substrates for SUMO
neck ring is that it consists of parallel septin filamentsattachment include proteins participating in transcrip-
traversing the bud neck parallel to the mother-bud axistional regulation, signal transduction, inflammation, and
(Field et al., 1996).control of cell growth (Melchior, 2000). The set of known
There are four major sumoylation-site Lys residues insumoylated proteins, which includes p53 and c-jun, is
Cdc3, one in Cdc11, and two in Sep7, all within thegrowing rapidly, suggesting that sumoylation may be a
consensus sequence (IVL)KX(ED) (Johnson and Blobel,widespread mechanism for controlling protein activity.
1999), which is also found at SUMO attachment sitesSUMO is 18% identical to ubiquitin (Ub), a highly con-
in mammalian proteins. A mutant lacking all these Lysserved, 76 residue protein that targets proteins for pro-
residues accumulates septin rings from previous cellteasome-dependent proteolysis, participates in endo-
cycles, but it grows well, indicating that the cell cyclecytosis, and serves several other functions (Hershko and
arrests in SUMO conjugation mutants do not arise fromCiechanover, 1998). Ub usually becomes attached to
a deficiency in septin sumoylation. SUMO attachmentits substrates via an isopeptide bond between the C
to septins is intricately regulated, occurring only on theterminus of Ub and the -amino group of an internal Lys
mother cell side of the bud neck and exclusively duringresidue in the substrate. Proteins to be degraded by the
mitosis, with conjugates appearing shortly before ana-proteasome are linked to a multiubiquitin chain, in which
phase onset and disappearing suddenly at cytokinesis.
successive copies of Ub are attached to an internal Lys
The SUMO and Ub conjugation pathways are distinct
in the previous Ub in the chain. SUMO is also attached
but share multiple similarities. Ub conjugation is carried
to substrates at internal Lys residues, but it does not out in three enzymatic steps, catalyzed by a Ub-activat-
target proteins for proteasome-dependent proteolysis. ing enzyme (E1), one of a family of Ub-conjugating en-
Instead, SUMO appears to modulate the ability of sub- zymes (E2s), and a Ub-protein ligase (E3) (Hershko and
strates to interact with other proteins. For example, Ciechanover, 1998). The Ub-substrate isopeptide bond
SUMO attachment targets RanGAP1 to the nuclear pore can also be cleaved by a family of deubiquitylating en-
complex by promoting binding to RanBP2/Nup358 (Ma- zymes (Dubs). The E1 for SUMO is a heterodimer of
hajan et al., 1997). In contrast, SUMO blocks ubiquityla- Aos1 and Uba2, proteins with sequence similarity to the
tion and degradation of the inflammatory response regu- N and C termini, respectively, of Ub E1s (Johnson et al.,
1997; Okuma et al., 1999). The SUMO pathway E2 is
Ubc9, a protein with strong sequence similarity to Ub1Correspondence: erica.johnson@mail.tju.edu
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E2s (Desterro et al., 1997; Johnson and Blobel, 1997). ine RING domains (38% identity to the BRCA1 RING),
but which lacks two of the absolutely conserved cyste-There are also specific proteases that cleave SUMO-
ine residues involved in Zn2 chelation. There is alsosubstrate isopeptide bonds, which are encoded by the
significant similarity between the Sizs and PIASs outsideyeast ULP1 and ULP2/SMT4 genes (Li and Hochstras-
the RING-related domain (25% identity over400 resi-ser, 1999, 2000; Schwienhorst et al., 2000). UBA2, AOS1,
dues), extending through most of the N-terminal regionUBC9, and ULP1 are all essential genes, and conditional
of Siz1 and Siz2. The PIAS proteins contain an “SXS”alleles display cell cycle defects.
motif, which promotes binding to SUMO in the yeastThe mechanism of regulation of SUMO conjugation
2-hybrid assay (Minty et al., 2000), and the Sizs containhas not been described for any substrate. In the Ub
a related motif at a similar position. The Sizs and mostpathway, E3s provide substrate specificity, and it is the
PIASs also contain regions that conform to the consen-interaction between the substrate and the E3 that is
sus sequence for the SAP domain, a motif implicatedregulated. Ubiquitylation E3s do not form a single family
in chromatin organization (Aravind and Koonin, 2000).of similar proteins and include a wide variety of mono-
Despite the striking reduction in SUMO conjugation,meric proteins as well as large multiprotein complexes.
the siz1 siz2mutant was viable, in contrast to mutantsSome examples of E3s are the HECT domain proteins
in other genes of the SUMO pathway. SMT3 (the gene(Huibregtse et al., 1995), N-recognin (Kwon et al., 1998),
encoding SUMO) and UBA2 were still essential in theSCF complexes (Deshaies, 1999), and the anaphase pro-
siz1 siz2mutant (not shown), indicating that the resid-moting complex (APC) or cyclosome (Page and Hieter,
ual conjugation in this mutant carries out SUMO’s essen-1999). Many E3s contain, or include a subunit con-
tial functions. When the siz1, siz2, and siz1 siz2taining, a Zn2 binding domain known as a RING domain
mutants were assessed for sensitivity to various stress(Joazeiro and Weissman, 2000).
conditions, the only notable effect was that the siz1We were interested in identifying proteins responsible
siz2 strain showed reduced plating efficiency, mostfor substrate specificity and regulation in septin sumo-
strikingly at lower temperatures (Figure 2A). Its platingylation, and found Siz1, which plays an E3-like role in
efficiency was 51% at 37C, 15% at 30C, and 8% atthe SUMO pathway.
20C, compared to 86%, 81%, and 76% for wt. With this
exception and taking into account the consistent growthResults
defect in the double mutant, none of these strains were
hypersensitive to either high or low temperatures, toSIZ1 and SIZ2 Are Required for Most SUMO
DNA damaging agents (UV light or methyl methane sul-Conjugation in Yeast
fonate), to hydroxyurea, to caffeine, or to the microtu-To identify additional proteins involved in septin sumo-
bule destabilizing drug thiabendazole (not shown). Theyylation, we examined known septin interacting proteins.
mated efficiently, and the single mutants sporulated withOne candidate, called Nfi1 (neck filament interacting)
the same efficiency as wt to produce viable segregants;had been found in a 2-hybrid screen with CDC12 and
the double mutant was not tested for sporulation (notcontained a region resembling a RING domain. NFI1 has
shown).
recently been renamed SIZ2 (SAP and Miz1 domains)
Microscopic examination revealed that siz1 siz2
(Strunnikov et al., 2001). A siz2 strain contained wild-
cultures contained many enlarged large-budded cells
type levels of SUMO-septin conjugates (Figure 1A) but
with nuclei in the early stages of nuclear division (Figure
lacked an unidentified 45 kDa SUMO conjugate, 2B), much like conditional mutants in the essential com-
prompting us to delete a related gene, SIZ1 (Strunnikov ponents of the SUMO pathway. To determine whether
et al., 2001). Deleting SIZ1 eliminated SUMO-septin con- this resulted from a cell cycle delay in all cells or from
jugates as well as virtually all SUMO conjugates in noco- an arrest or prolonged delay in a subpopulation, we
dazole-arrested cells. The siz1 strain also contained examined cell cycle progression in -factor synchro-
dramatically reduced levels of SUMO conjugates in log- nized cultures (Figure 2C). After 3 hr in -factor, the vast
arithmically growing cells. The remaining conjugates majority of wt cells arrested in G1. Sixty minutes after
were mostly SIZ2-dependent, as deletion of both SIZ1 release from -factor arrest, almost all of these cells
and SIZ2 resulted in further reduction of SUMO conjuga- had completed DNA replication. At this point, -factor
tion. However, siz1 siz2 cells did contain low levels was readded to prevent a second cell cycle. By 90 min,
of SUMO conjugates, indicating that not all yeast SUMO many cells had undergone cytokinesis, and over the
conjugation is SIZ1 and SIZ2 dependent. next 60–90 min, virtually all cells divided and rearrested
Siz1 and Siz2 are 904 and 726 amino acid proteins, in G1. In contrast, the siz1 siz2 mutant contained a
respectively, and are 42% identical to each other over large population of cells with 2C DNA content even after
an 470 residue N-terminal domain (Figure 1B). Both 3 hr in -factor, although other cells arrested and formed
proteins have C-terminal extensions with no similarity mating projections as wt (not shown). Like wt, by 60
to each other or to other known proteins. There are no min, virtually all G1-arrested mutant cells had completed
other similar genes in S. cerevisiae, but other eukaryotes replication. Strikingly, many of these cells underwent
contain related proteins. Many of these are members of cytokinesis and progressed to G1 at the same rate as
the PIAS (protein inhibitor of activated STAT) family, wt, while other cells remained arrested with 2C DNA
which were identified based on their ability to bind STAT content. When large-budded siz1 siz2 cells from an
transcription factors and prevent STAT-activated tran- -factor-arrested culture were picked with a micromani-
scription (Shuai, 2000). One striking feature of this family pulator and incubated at 36C, 85% divided at least
is a conserved domain related to a C3HC4 RING domain once, and 30% formed viable colonies (not shown), indi-
cating that most of these cells are competent to com-(Figure 1C), which shows substantial similarity to genu-
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Figure 1. SIZ1 and SIZ2 Promote SUMO
Conjugation In Vivo
(A) Whole-cell lysates from log phase (lanes
1–5) or nocodazole-arrested (lanes 6–17) cells
expressing Cdc3-HA were analyzed by SDS-
PAGE and immunoblotting with Abs against
SUMO (lanes 1–9), the HA epitope (lanes 10–
13), or Cdc11 (lanes 14–17). Genotypes are
indicated over the lanes. Lane 5 is an overex-
posure of lane 4. Arrows indicate unmodified
Cdc3-HA (lanes 10–13) and Cdc11 (lanes
14–17).
(B) Alignment of Siz1, Siz2, and human PIASy.
Gray lines indicate identities between at least
two proteins and black lines among all three.
The SAP domain, RING-related domain, and
SXS-like motif are indicated.
(C) Alignment of the RING-related motifs in
Siz1, Siz2, and PIASy to RING domain from
BRCA1. Residues identical in at least two
proteins are shaded black, and conserved
residues gray. The conserved Zn2-chelating
residues are indicated. Asterisks mark resi-
dues missing in the Siz family.
plete mitosis and undergo further cell divisions. Thus, of abnormal cells, and other very small but visible colo-
nies containing a few hundred enlarged, inviable cellssome siz1 siz2 cells proceed through the cell cycle
at wild-type rates, while others enter a prolonged delay (Figure 2A). This pattern of growth, along with the plating
efficiency data, suggested that certain cells containedor arrest. Another indication of the heterogeneity of
siz1 siz2 cells was that the colonies formed at 20C a heritable defect such that if they were grown at 20C,
their lineage would grow for a while, but ultimately dievaried dramatically, with some nearly wt-sized colonies
containing mostly normal-looking cells but with sectors out; whereas if they were grown at 36C, the defect
Figure 2. siz1 siz2 Mutants Are Cold Sen-
sitive and Accumulate in G2/M
(A) wt and siz1 siz2 cells were incubated
on YPD plates at 20C for 4 days or 36C for
2 days.
(B) Microscopy of wt (a) or siz1 siz2 (b and
c) cells grown at 30C using Nomarski optics
(a and b) or DAPI staining (c). Bar, 10 m.
(C) Flow cytometry of propidium iodide
stained cells from a timecourse after release
from -factor arrest of wt or siz1 siz2
strains. Cells were preincubated in -factor
for three hours at 30C. At 0 min, -factor was
washed out, and incubation at 30C contin-
ued with time points taken every 30 min. At
60 min, -factor was readded to prevent a
second cell cycle.
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would be repaired and the lineage would continue. One
possible source of such an effect could be a defect in
telomere maintenance, as is seen in S. pombe SUMO
mutants (Tanaka et al., 1999). However, telomeres in the
siz1 siz2 strain were the same length as in wt cells
(not shown).
We have previously observed that cells lacking the
SUMO attachment sites on their septins accumulate
remnants of septin rings from previous cell divisions
(Johnson and Blobel, 1999). However, we were unable
to observe old septin rings in siz1 cells by immunofluo-
rescence microscopy against either HA-tagged Cdc3 or
Cdc11. The cdc3 attachment site mutant is also synthet-
ically lethal with a cdc12-1 mutant, while the siz1
cdc12-1 strain was viable. These results suggest that
the Lys to Arg mutations at the SUMO attachment sites
in the septins also affect some process other than SUMO
conjugation.
Cell Cycle-Dependent Bud Neck Localization
and Phosphorylation of Siz1
To determine Siz1’s subcellular localization, Siz1 was
C-terminally tagged with enhanced green fluorescence
protein (GFP). This fusion was functional and restored
septin sumoylation in a siz1 strain. Siz1-GFP localized
both to the bud neck and to the nucleus, where its
distribution was somewhat punctate (Figure 3A). Bud
neck localized Siz1-GFP was observed exclusively in
Figure 3. Cell Cycle- and Septin-Dependent Bud Neck Localizationlarge-budded cells, never in unbudded or small-budded
of Siz1cells. Nocodazole-arrested cells all displayed bud neck
(A) Siz1-GFP expressed from p416-Siz1-GFP in log phase EJY333localized Siz1-GFP, usually as a single ring colocalizing
was detected by fluorescence microscopy. Bar, 5 m.
with the mother cell side of the bud neck (Figures 3B (B) EJY333 cells overexpressing Siz1-GFP from pSiz1-GFP were
and 3C), although sometimes Siz1-GFP was present on prepared for immunofluorescence microscopy and analyzed for
both sides of the septin ring. These results were consis- Siz1-GFP (a and d); with an Ab against Cdc11 (b and e) or by DAPI
staining (c and f). (a), (b), and (c) and (d), (e), and (f) are two differenttent with our previous observation that SUMO is attached
cells. Bar, 5 m.only on the mother cell side of the bud neck in mitotic
(C) ubc9 ts (a and b; lanes 1 and 2) or cdc10-1 ts (c and d; lanescells of log phase cultures but is frequently on both
3 and 4) strains expressing Siz1-GFP from p416-Siz1-GFP were
sides in nocodazole-arrested cells (Johnson and Blobel, transferred from SD to YPD, grown at 20C for 2 hr, nocodazole
1999). Bud neck localization of Siz1 depended on the arrested for 3 hr at 20C, and either held at 20C for an additional1
septins, as Siz1-GFP disappeared from the bud neck hr (a and c; lanes 1 and 3) or shifted to 37C for 1 hr (b and d;
lanes 2 and 4). Siz1-GFP localization was observed by fluorescencewhen nocodazole-arrested cdc10-1 cells were shifted
microscopy (a–d). Bar, 5 m. Whole-cell lysates were analyzed byto the nonpermissive temperature, which results in dis-
SDS-PAGE and immunoblotting with Abs against SUMO (top panel),assembly of the septin ring (Figure 3C; not shown). How-
Ubc9 (middle panel), or Cdc11 (bottom panel). SUMO-Cdc11 is visi-
ever, bud neck localization of Siz1-GFP did not require ble in lanes 1 and 3 on a longer exposure.
Ubc9 or sumoylated septins, as it was still present in a
ubc9-Pro69Ser mutant at the nonpermissive tempera-
ture, where the mutant Ubc9 protein is rapidly degraded phosphorylated (Figure 4B). Thus, Siz1 phosphorylation
coincided with the period during the cell cycle when Siz1(Betting and Seufert, 1996) and SUMO-septin conju-
gates disappeared (Figure 3C). localized to the bud neck and when septin sumoylation
takes place.To ask whether Siz1 is posttranslationally modified
during the cell cycle, the genomic copy of SIZ1 was
tagged with the influenza virus hemagglutinin (HA) epi- Reconstitution of Septin Sumoylation In Vitro
To determine whether Siz1 plays a direct role in SUMOtope tag (Field et al., 1988). The HA-tagged version was
functional, and septin sumoylation took place as in wt. conjugation, we reconstituted septin sumoylation in
vitro using purified proteins. This task was complicatedWhen these cells were arrested with nocodazole, Siz1
shifted quantitatively into a higher molecular weight by the facts that crude yeast lysate did not conjugate
SUMO to septins and that Siz1 stimulation of sumoyla-form, while cells arrested in late anaphase/telophase by
a ts mutation in the mitotic exit gene CDC15 contained tion was inhibited by very low concentrations of the
nonionic detergent Triton X-100 or by buffering concen-approximately equal amounts of the lower and higher
forms of Siz1 (Figure 4A). Treatment of Siz1 isolated trations of Tris. The in vitro reaction was originally estab-
lished using E. coli-produced SUMO, Uba2/Aos1 (E1),from nocodazole-arrested cells with lambda protein
phosphatase shifted the higher form into the lower, indi- and Ubc9 (E2), but with tagged septins affinity purified
from log phase yeast and tagged Siz1 overexpressedcating that the higher molecular weight species was
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carrier. Furthermore, formation of any SUMO conjugates
depended strongly on inclusion of septins as substrates
(Figure 6). However, when 10-fold more E1 and E2 were
present, substantial septin sumoylation occurred in the
absence of Siz1 (Figure 5A). Adding Siz1 greatly in-
creased SUMO conjugation under these conditions as
well, as almost all of the vast excess of SUMO was
incorporated into higher molecular weight species (Fig-
ures 5A and 6). Surprisingly, Siz1’s effect did not depend
on its phosphorylation, as recombinant Siz1 isolated
from E. coli had a similar effect. Noting the limits of this
semiquantitative assay, recombinant Siz1 appeared to
be approximately equally active as the yeast-expressed
phosphorylated Siz1 (Figure 5A).
To prove definitively that no uncharacterized yeast
proteins copurifying with the septins were affecting this
reaction, it would have been preferable to replace the
yeast septins with recombinant septins. Cdc3, Cdc10,
Cdc11, and Cdc12 were produced in E. coli, but the
weak E1- and E2-induced sumoylation of recombinant
Cdc3 and Cdc11 was not stimulated by Siz1, even when
the other septins were included in the reaction (not
shown). Possible explanations are that these did not
assemble correctly into the multimer capable of poly-Figure 4. Siz1 Undergoes Cell Cycle-Dependent Phosphorylation
merizing or that other modifications of the septins areand Binds Ubc9
required for Siz1-dependent sumoylation. However, we(A) Whole-cell lysates of log phase, cdc15-arrested or nocodazole-
believe it is unlikely that proteins copurifying with thearrested cells expressing HA-tagged Siz1 were analyzed by SDS-
PAGE and immunoblotting with a mAb against the HA epitope. yeast septins were required for stimulating sumoylation,
Bands containing Siz1-HA are indicated. A dot designates a band because this septin preparation was affinity purified un-
that cross-reacts with the anti-HA antibody. der very stringent conditions, including washes with
(B) His6- and FLAG-tagged Siz1 isolated from nocodazole-arrested buffers containing 1M NaCl or 1% Triton X-100 and 0.1%
yeast was mock treated, treated with lambda protein phosphatase
SDS. Any protein that remained bound probably would(-PPase), or treated with -PPase in the presence of the phospha-
not have an off rate high enough to act catalytically intase inhibitor Na3VO4. Products were detected by immunobloting
the sumoylation of more than half the Cdc3 and Cdc11with an Ab against the FLAG epitope.
(C) Preparations of septins (lane 1), phosphorylated His6- and FLAG- present in the reaction.
tagged Siz1 from nocodazole-arrested yeast (lane 2), and E. coli- Siz1 also promoted formation of chains containing
produced His6- and FLAG-tagged Siz1 (lane 3) were analyzed by SUMO-SUMO isopeptide bonds. In reactions containing
SDS-PAGE and staining with Coomassie brilliant blue. Full-length only SUMO, E1, and E2, a band of an appropriate sizeSiz1 is indicated.
to be di-SUMO formed in the presence of low concentra-(D) Whole-cell lysate from E. coli expressing Siz1-HF was incubated
tions of E1 and E2 (Figure 6). When 10-fold more E1 andwith ethanolamine-blocked Affi-gel 10 beads (lanes 1 and 2) or with
E2 were added, a ladder of bands formed. If the SUMOUbc9-coupled Affi-gel 10 beads (lanes 3 and 4). Unbound (lanes 1
and 3) and bound (lanes 2 and 4) Siz1-HF-derived proteins were was reductively methylated (me-SUMO), blocking Lys
detected by immunobloting with an Ab against the FLAG epitope. residues to isopeptide bond formation, the ladder was
Lane 5, total protein. Full-length Siz1-HF is indicated. Dots indicate eliminated. Instead, a single SUMO-containing product
C-terminal fragments of Siz1-HF.
formed, which was probably an adduct of SUMO and
Ubc9. Addition of recombinant Siz1 to these reactions
stimulated formation of the higher molecular weight
in and affinity purified from nocodazole-arrested yeast forms, especially in the presence of high E1 and E2,
(Figure 4C). This Siz1 was quantitatively phosphorylated where virtually all of the SUMO was incorporated into
(Figure 4B). We had previously determined that no pro- higher molecular weight species, even when no septins
teins copurified in stoichiometric quantities with tagged were present. me-SUMO dramatically reduced forma-
Siz1 expressed from its own promoter, indicating that tion of these species: the major low molecular weight
it is not part of a stable complex (not shown). Ubc9 does bands that are likely to be di-SUMO, tri-SUMO, etc. were
bind Siz1 in vitro (Figure 4D), but was probably removed completely eliminated, and only a small fraction of the
in the wash in this experiment. methylated SUMO was incorporated into high molecular
With lower concentrations of E1 and E2 in the reaction, weight conjugates. However, there were many high mo-
conjugation of SUMO to both Cdc3 and Cdc11 was lecular weight species in these reactions that could not
strongly dependent on addition of Siz1, and increasing be explained. Addition of me-SUMO to the septin reac-
the concentration of Siz1 increased the proportion of tions also eliminated the extremely high molecular
the septins that were sumoylated (Figure 5A). SUMO weight forms of Cdc3 and Cdc11 (Figure 5B). Cdc3 ap-
conjugation took place primarily on the major in vivo peared to have approximately 4–7 copies of SUMO
attachment site Lys residues in Cdc3 and Cdc11 (Figure attached, close to the genuine number of SUMO attach-
5B), and was specific for genuine SUMO substrates, as ment sites on Cdc3; Cdc11 also showed lower molecular
weight conjugates, although many of these were muchCdc12 was not modified, nor was BSA present as a
Cell
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Figure 5. Reconstitution of SUMO Conjugation to the Septins In Vitro
(A) Septins and SUMO were incubated for 90 min at 30C with 5 mM ATP (lanes 2–10), recombinant Uba2/Aos1 and Ubc9 (E1 and E2; 10-
fold more in lanes 1 and 8–10 than in lanes 2–7), and varying amounts of phosphorylated Siz1 (1	 in lane 3, 5	 in lanes 4 and 9, and 25	 in
lanes 1 and 5) or recombinant Siz1 (1	 in lane 6 and 5	 in lanes 7 and 10). Septins and Siz1 were present in the proportions shown in Figure
4C in lanes 1 and 5 for phosphorylated Siz1 and lanes 7 and 10 for recombinant Siz1. Septins were detected by immunoblotting with Abs
against HA for Cdc3-HA (top panel), against Cdc11 (middle panel), or against the FLAG epitope (lower panel). Proteins detected are indicated.
Dots designate bands that contain C-terminal fragments of recombinant Siz1. Note that Cdc12 and Siz1 both bear the FLAG epitope tag.
Siz1 rapidly becomes undetectable in these reactions, probably because of aggregation.
(B) Reactions contained Uba2/Aos1, Ubc9, ATP, phosphorylated Siz1 (lanes 2, 4, 6, 8, 10, 11, 13, and 14), wt septins (lanes 1, 2, 5, 6, and
9–14), septins from EJY334 expressing Cdc3-R4,11,30,63-HA (lanes 3 and 4), septins from EJY335 expressing Cdc11-R412-HA (lanes 7 and
8), SUMO (lanes 1–10, 12, and 13), or reductively methylated SUMO (me-SUMO; lanes 11 and 14). Cdc3-HA and Cdc11 were detected by
immunoblotting. Bands containing unmodified Cdc3 and Cdc11 are indicated by arrows.
larger than expected given that only one to two copies This reaction did not take place if ATP, the E1, or the
E2 were absent or if the thiolester-forming Cys in Ubc9are attached in vivo. These bands are also unexplained.
The quantitative incorporation of Cdc3 and Cdc11 into was mutated to a Ser (not shown), demonstrating depen-
dence on the E2 intermediate. The bonds formed weremodified forms suggests that me-SUMO acts primarily
by preventing SUMO from acting as a substrate rather amide bonds, as in vitro septin sumoylation required
the previously defined SUMO attachment site Lys resi-than by inhibiting the activation pathway. These data
indicate that SUMO can be covalently attached to itself, dues in Cdc3 and Cdc11, and as SUMO polymerization
was dramatically inhibited by reductive methylation ofthat Siz1 stimulates this activity even in the absence of
any yeast-derived proteins, and that SUMO polymeriza- SUMO.
Siz1 also interacted with the septins, at least indi-tion can take place either on another protein or as a
chain containing only SUMO. rectly. Siz1 showed septin-dependent localization to the
bud neck, and this localization coincided exactly with
the timing and location of SUMO attachment. Siz1 alsoDiscussion
showed the genetic hallmark of an E3 with respect to
substrate specificity: it was required for sumoylation ofBased on our results, we propose that Siz1 plays a role
analogous to that of E3s in the Ub pathway. “E3s” are some substrates (the septins), but not of others (the
45 kDa Siz2-dependent conjugate). We were unable todefined as having three characteristics: they bind the
substrate (either directly or indirectly); they bind the E2; demonstrate direct binding between Siz1 and the septin
complex, in part because neither purified septins norand, most importantly, they stimulate transfer of Ub from
the E2-Ub thiolester intermediate to an amide bond with purified Siz1 was stable enough in solution to be used
in the soluble phase. However, the in vivo interactioneither the substrate or with another Ub moiety (Hershko
and Ciechanover, 1998). Siz1 did bind the E2 Ubc9, and between Siz1 and the septins is likely to involve other
factors, acting either positively or negatively, as Siz1it also clearly met this third criterion, as it stimulated
transfer of SUMO both to septins and to SUMO itself. localized preferentially only to one side of the bud neck,
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some Ub E2s can attach Ub to other proteins in vitro in
the absence of E3s, and some are also capable of E3-
independent formation of Ub chains with branch sites
at specific Lys residues (Chen et al., 1991). Thus, this
difference between the SUMO and Ub pathways ap-
pears to be more in the degree of specificity provided
by the E2 rather than a fundamental difference in E2
activity. Siz1 would only differ fundamentally from Ub
E3s if Ubc9 provided all the substrate specificity, leaving
Siz1 to stimulate transfer of SUMO to any substrate
selected by Ubc9. This seems unlikely, as Siz1’s local-
ization to the bud neck is independent of Ubc9 and
as Siz1 stimulates SUMO attachment to some, not all,
substrates in vivo.
The observation that Siz1 localized to the mother cell
side of the bud neck exclusively during mitosis, coincid-
ing with the place and time that septins are sumoylated,
suggested that Siz1 may participate in the cell cycle
and mother-bud regulation of this modification. OneFigure 6. Siz1 Promotes Polymerization of SUMO
model for how Siz1 could participate is that the mitosis-Reactions contained SUMO (lanes 1–9) or reductively methylated
specific phosphorylation might promote Siz1’s associa-SUMO (lanes 10–13), varying amounts of Uba2/Aos2 and Ubc9 (E1
tion with some feature of the mother cell side of the budand E2; 10-fold more in lanes 1 and 6–13 than in lanes 2–5), phos-
phorylated Siz1 (lane 1), recombinant Siz1 (lanes 4, 5, 8–10, 12, and neck, thereby stimulating SUMO conjugation only in this
13), septins (lanes 1, 3, 5, 7, 9, and 13) and 5 mM ATP (lanes 2–13). zone at this point in the cell cycle.
SUMO was detected by immunoblotting. Reactions in lanes 1, 3, 5, Another issue is whether chains of SUMO, analogous
7, and 9 are the same as in Figure 5A, lanes 1, 2, 7, 8, and 10,
to the chains formed by Ub, form in vivo as they didrespectively. The band containing free SUMO is indicated. Arrows
in vitro. Formation of these chains depended on thedesignate bands that are likely to be di-SUMO, tri-SUMO, etc.
concentrations of SUMO, E1, and E2, and when any of
these were limited, especially SUMO, chain formation
was dramatically reduced (not shown). In vivo, there iswhile septins, obviously, were present on both. Also,
very little free unconjugated SUMO (Johnson et al.,only very low levels of Siz1 appeared to bind to the bud
1997), which would probably limit the formation of chains.neck. A highly overexpressed Siz1-GFP fusion was quite
A SUMO-SUMO branch site has recently been identifieddifficult to detect at the bud neck (Figure 3B), while
in the N-terminal domain of mammalian SUMO-2 (TathamCdc12-GFP expressed from the same promoter in the
et al., 2001), and there is a repeat with a related sequencesame plasmid is very bright (Johnson and Blobel, 1999).
in yeast SUMO. Identifying and mutating the branch site
Overexpression of Siz1 also did not increase the propor-
should clarify the physiological role of SUMO polymer-
tion of septins sumoylated in vivo, even when SUMO
ization.
was cooverexpressed, and despite the fact that Siz1
The phenotype of the siz1 mutant was consistent
was quantitatively phosphorylated (not shown). This with that of the mutant lacking sumoylation sites on the
may be because another enzyme of the SUMO pathway septins, insofar as both grew well and had few obvious
was limiting, because overexpressed Siz1 formed ag- phenotypes. The siz2 strain was also without striking
gregates, or it could be because some other factor limits phenotypes, but the siz1 siz2 strain grew poorly, sug-
the amount of Siz1 that localizes at the bud neck. Many gesting that SIZ1 and SIZ2 act redundantly with regard
proteins show septin-dependent bud neck localization, to the substrate(s) involved in the growth defect. A re-
some only to one side or the other of the bud neck, cent paper states that the siz1 siz2 mutant is inviable
and one of these could either prevent or promote Siz1 (Strunnikov et al., 2001), but it is likely that this resulted
binding in vivo. from incubating tetrad dissections at 23C, where most
Thus, Siz1 fulfills all three aspects of this definition of siz1 siz2 cells do not form viable colonies. It is also
an E3. However, an E3-like activity for SUMO is some- possible that a strain difference is responsible.
what different from that for Ub because the E2 Ubc9 Another question raised by our results is whether
binds directly to at least some substrates, in interactions there are other E3-like factors for SUMO in yeast that
involving the sumoylation site consensus sequence are unrelated to Siz1 and Siz2, or whether Ubc9 carries
(Sampson et al., 2001) or other sequences in the sub- out a low level of sumoylation unassisted by an E3 in
strate (Buschmann et al., 2001). Purified E1 and Ubc9 vivo. While there is no way to prove or disprove the
alone attach SUMO to RanGAP1 (Okuma et al., 1999; existence of another E3 except by identifying it, the
Sampson et al., 2001), IB (Desterro et al., 1999), and ability of Ubc9 to bind directly to some substrates sug-
to the septins (Figure 5) in vitro, and these reactions are gests Ubc9 may carry out E3-independent sumoylation.
specific for the correct sumoylation sites. In contrast, However, in yeast, the majority of SUMO conjugation
no consensus attachment sites have been identified for required SIZ1 or SIZ2, and dependence on other factors
ubiquitylation, which can often take place on any one is likely to be common in vivo in other organisms as
of a number of Lys residues in the substrate. There is well. The sequence similarity between the Sizs and pro-
also no evidence that Ub E2s engage in E3-independent teins of the PIAS family suggests that this whole family
may be involved in SUMO conjugation. The PIAS pro-binding or ubiquitylation of substrates in vivo. However,
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Table 1. S. cerevisiae Strains
Name Relevant genotype Source
YWO102 MAT ubc9::TRP1 leu2::ubc9Pro-Ser::LEU2 Seufert et al., 1995
JD52 MATa trp1-1 ura3-52 his3-200 leu2-3,112 lys2-801 J. Dohmen
EJY324 MATa siz2::TRP1 This study
EJY325 MATa siz1::LEU2 This study
EJY326 MATa siz1::LEU2 siz2::TRP1 This study
EJY301 MATa CDC3-HA::HIS3 Johnson and Blobel, 1999
EJY327 MATa CDC3-HA::HIS3 siz2::TRP1 This study
EJY328 MATa CDC3-HA::HIS3 siz1::LEU2 This study
EJY329 MATa CDC3-HA::HIS3 siz1::LEU2 siz2::TRP1 This study
EJY330 MATa SIZ1-HA::HIS3 This study
EJY331 MATa SIZ1-HA::HIS3 cdc15-2::URA3 This study
EJY332 MATa CDC3-HA::HIS3 CDC12-HF::TRP1 This study
EJY333 MATa/MAT siz1::TRP1/siz1::TRP1 This study
EJY334 MATa cdc3-R4,11,30,63-HA::TRP1 CDC12-FLAG::LEU2 This study
EJY335 MATa cdc11-R412-HA::HIS3 CDC12-FLAG::LEU2 This study
EJY336 MAT cdc10-1::TRP1 This study
purified rabbit polyclonal Ab against Smt3 (SUMO) (Johnson andteins were isolated via their ability to bind to STAT tran-
Blobel, 1999), the 16B12 mAb against the HA epitope (BAbCO), thescriptional activators, but there is no evidence that STAT
M2 mAB against the FLAG epitope (IBI/Kodak), a rabbit polyclonalproteins are sumoylated. However, one member of this
Ab against Cdc11 (Santa Cruz Biotechnology), and a goat polyclonal
family, ARIP3, was isolated through its interaction with Ab against Ubc9 (yC-19) (Santa Cruz Biotechnology).
the androgen receptor (Moilanen et al., 1999), which is
sumoylated (Poukka et al., 2000). The role of the PIAS Affinity Purification of Epitope-Tagged Proteins
family in mammalian SUMO conjugation is an intriguing His6-SUMO, Ubc9-His6, and His6-Aos1/Uba2-His6 were expressed in
E. coli and purified by Ni-NTA affinity chromatography as describedarea for future research.
(Johnson and Blobel, 1997; Johnson et al., 1997), except cells were
lysed with Y-PER (Pierce) and Aos1 and Uba2 were coexpressedExperimental Procedures
in the same cells. SUMO and Ubc9 preparations were 
99% pure
and the Uba2/Aos1 preparation 
90%. His6-SUMO was reductivelyMedia and Genetic Techniques
Standard techniques were used (Ausubel et al., 2000). Rich yeast methylated as described (White and Rayment, 1993).
Septins were purified from log phase EJY332, EJY334, or EJY335media, containing either 2% glucose (YPD) or 2% raffinose (YPR),
and synthetic yeast media (SD) were prepared as described (Sher- cells in a variation of the method in Frazier et al. (1998). Cells from
an A600  1 culture were harvested by centrifugation, washed inman et al., 1986). Cell cycle arrests were induced by incubating for
3 hr with 10 M -factor (Sigma) or 15 g/ml nocodazole (Acros). water, frozen dropwise in liquid N2, ground with a mortar and pestle
under liquid N2 to a fine powder, and extracted at 4C with 10–20
volumes of buffer A (50 mM sodium phosphate [pH 8.0], 300 mMPlasmids and Yeast Strain Constructions
Plasmids for expressing His6-tagged Uba2 and Ubc9 in E. coli have NaCl, and 0.2% Triton X-100) plus 50 mM Tris (pH 8.0), 2 g/ml of
the protease inhibitors antipain, aprotinin, chymostatin, leupeptin,been described (Johnson and Blobel, 1997; Johnson et al., 1997).
His6-tagged AOS1 was transferred to pET28a (Novagen), so that and pepstatin, plus 5 mM NaF and 200 M Na3VO4. Subsequent
steps were done at 4C. Cell debris was pelleted at 27,000 	 gmax,Uba2 and Aos1 could be coexpressed. A pET21b-based plasmid
expressed His6-tagged Smt3 (SUMO) bearing the N-terminal exten- and the resulting supernatant bound in batch for 2–3 hr to anti-
FLAG Ab agarose (IBI/Kodak). Beads were loaded into a columnsion MASMHHHHHH. A pET21a-based plasmid expressed Siz1
bearing the FLAG epitope and His8-containing C-terminal extension and washed with 50–100 column volumes of: (1) buffer A, (2) TBS-T
(25 mM Tris [ pH 7.5], 150 mM NaCl, and 0.1% Tween-20), (3) RIPAGDYKDDDDKRGSHHHHHHHH. p424GAL-Siz1-HF was a p424GAL1-
based (Mumberg et al., 1994) plasmid for galactose-inducible ex- (50 mM Tris [pH 7.5], 150 mM NaCl, 5 mM EDTA, and 1% Triton
X-100) with 0.1% SDS, and (4) buffer B (50 mM Tris, 1 M NaCl, andpression of the same tagged version of Siz1 in yeast. pSiz1-GFP is
a pYX242-GFP-based (Rosenblum et al., 1998) plasmid expressing 1 mM MgCl2) plus 0.2% Triton X-100, and eluted with 75 g/ml FLAG
peptide (Sigma) in buffer B plus 0.2% Triton X-100. Eluate wasSiz1 with a C-terminal enhanced GFP tag from the TPI1 promoter.
p416-Siz1-GFP expressed the same fusion from the SIZ1 promoter. bound for 2 hr in batch to Ni-NTA agarose, washed with buffer B
plus 0.2% Triton X-100, followed by buffer B, and eluted in bufferConstruction details available on request.
S. cerevisiae strains used are listed in Table 1. All strains are B containing 200 mM imidazole.
Phosphorylated Siz1-His6-FLAG was purified from EJY325 cellsderivatives of JD51 (Dohmen et al., 1995) except for YWO102, de-
rived from DF5 (Seufert et al., 1995), and EJY333, which was made containing p424GAL-Siz1-HF, that were grown to A600  0.8 in SD 
Trp containing 2% raffinose, harvested, resuspended to A600  0.8from the W303-derived (Thomas and Rothstein, 1989) ade3 mutant
strains W1536-5B and W1536-8B, generous gifts of Dr. Rodney in YPR, and incubated at 30C for 1 hr before addition of 15 g/ml
nocodazole, followed by incubation at 30C for 2 hr. Galactose wasRothstein. Strains were constructed as described (Johnson and
Blobel, 1999). Construction details and oligonucleotide sequences then added to 2% and incubation continued for 3 hr. Cells were
harvested and Siz1-HF isolated exactly as the septins except thatare available on request. The HA epitope-containing sequence on
CDC3 and SIZ1 encodes the C-terminal extension GYPYDVPDY- the wash of the anti-FLAG column with RIPA buffer plus 0.1% SDS
was omitted, and that 0.1 mM ZnCl2 was included in Ni-NTA columnAAFL. The FLAG and His8-containing sequence on Cdc12 (CDC12-
HF) is the same as on Siz1-HF. The FLAG sequence on Cdc12 in steps and in elution buffer. Recombinant Siz1-HF was expressed
approximately as SUMO, Ubc9, and Uba2/Aos1 except using BL21EJY334 and EJY335 encodes DYKDDDDK.
CodonPlus (DE3)-RIL cells (Stratagene) as the host and inducing
with 0.1 mM IPTG for 4 hr at 20C in LB amp supplemented withAntibodies and Immunoblot Analyses
Yeast whole-cell lysates were prepared as in Yaffe and Schatz (1984) 10 M ZnCl2. Cells were extracted with Y-PER supplemented with
1 mM PMSF and protease inhibitors as for the yeast septin prepara-and subjected to immunoblotting followed by chemiluminescent
detection (Johnson and Blobel, 1999). Antibodies were an affinity- tion; cell debris was pelleted, and supernatant was diluted 10-fold
An E3-like Factor in the SUMO Pathway
743
with buffer A plus 50 mM Tris and protease inhibitors as for yeast Seidman, J.G., and Struhl, K. (2000). Current Protocols in Molecular
Biology (New York: Wiley-Interscience).lysates. Subsequent steps were as for purification of Siz1 from yeast
lysate. Betting, J., and Seufert, W. (1996). A yeast Ubc9 mutant protein
Ubc9 binding assay was performed using Ubc9-His6 coupled to with temperature-sensitive in vivo function is subject to conditional
Affi-gel 10 (Bio-Rad) according to the manufacturer’s instructions proteolysis by a ubiquitin- and proteasome-dependent pathway. J.
(15 g Ubc9 / l beads) or uncoupled Affi-gel 10 beads blocked Biol. Chem. 271, 25790–25796.
with ethanolamine. E. coli expressing Siz1-HF were extracted with
Buschmann, T., Lerner, D., Lee, C., and Ronai, Z. (2001). Ubc-9
Y-PER, the supernatant diluted 5-fold with buffer C (50 mM HEPES
binding, which is required for SUMO-1 conjugation to Mdm2, is
(pH 7.0), 150 mM NaCl, and 0.2% Triton X-100), and 100 g total
mapped to N-terminal region of Mdm2 and is reduced following UV-
protein rotated with 10 l beads for 1 hr at 4C. Supernatant was
irradiation. J. Biol. Chem., in press.
retained as unbound fraction; beads were washed 3 times with
Chen, Z.J., Niles, E.G., and Pickart, C.M. (1991). Isolation of a cDNAbuffer C, and the bound fraction removed by boiling in SDS loading
encoding a mammalian multiubiquitinating enzyme (E225K) and over-buffer.
expression of the functional enzyme in Escherichia coli. J. Biol.
Chem. 266, 15698–15704.In Vitro Sumoylation Assay
Deshaies, R.J. (1999). SCF and Cullin/Ring H2-based ubiquitin li-In vitro reactions were performed immediately after elution of Siz1
gases. Annu. Rev. Cell Dev. Biol. 15, 435–467.and septin preparations. Reactions in Figure 5A and Figure 6 were
done at the same time using the septin and Siz1 preparations shown Desterro, J.M., Thomson, J., and Hay, R.T. (1997). Ubch9 conjugates
in Figure 4C. Reactions were performed in siliconized tubes and SUMO but not ubiquitin. FEBS Lett. 417, 297–300.
contained 50 mM HEPES (pH 7.0), 100 mM NaCl, 10 mM MgCl2, Desterro, J.M., Rodriguez, M.S., and Hay, R.T. (1998). SUMO-1 modi-
0.1 mM dithiothreitol, 20 g/ml bovine serum albumin (Fraction V; fication of IB inhibits NF-B activation. Mol. Cell 2, 233–239.
Sigma), 5 mM Tris, 20 mM imidazole, 5 M ZnCl2 (NaCl, Tris, imidaz-
Desterro, J.M., Rodriguez, M.S., Kemp, G.D., and Hay, R.T. (1999).ole, and ZnCl2 were added as part of the septin and Siz1 fractions
Identification of the enzyme required for activation of the smallor separately in the controls), and the following as noted: 5 mM
ubiquitin-like protein SUMO-1. J. Biol. Chem. 274, 10618–10624.ATP; 40 g/ml SUMO or reductively methylated SUMO; 2.5 g/ml
Dohmen, R.J., Stappen, R., McGrath, J.P., Forrova, H., Kolarov, J.,septin preparation; either 22 g/ml Uba2/Aos1 and 10 g/ml Ubc9
Goffeau, A., and Varshavsky, A. (1995). An essential yeast geneor 2.2 g/ml Uba2/Aos1 and 1 g/ml Ubc9; either 2.5 g/ml, 0.5
encoding a homolog of ubiquitin-activating enzyme. J. Biol. Chem.g/ml, or 0.1 g/ml of phosphorylated Siz1; or 13.5 g/ml or 2.7
270, 18099–18109.g/ml of the recombinant Siz1 preparation, which contained primar-
ily C-terminal fragments of Siz1 and E. coli proteins. Visual inspec- Field, C.M., al-Awar, O., Rosenblatt, J., Wong, M.L., Alberts, B., and
tion of Coomassie stained gels loaded with phosphorylated and Mitchison, T.J. (1996). A purified Drosophila septin complex forms
recombinant Siz1 preparations suggested that there were approxi- filaments and exhibits GTPase activity. J. Cell Biol. 133, 605–616.
mately equal amounts of full-length Siz1 in the reactions containing Field, J., Nikawa, J., Broek, D., MacDonald, B., Rodgers, L., Wilson,
0.5 g/ml phosphorylated Siz1 and 13.5 g/ml of the recombinant I.A., Lerner, R.A., and Wigler, M. (1988). Purification of a RAS-respon-
preparation. Reactions in Figure 5B were performed with different sive adenylyl cyclase complex from Saccharomyces cerevisiae by
preparations of septins and Siz1 that had not been subjected to use of an epitope addition method. Mol. Cell. Biol. 8, 2159–2165.
Ni-NTA chromatography. They contained the same buffer, except
Frazier, J.A., Wong, M.L., Longtine, M.S., Pringle, J.R., Mann, M.,lacking imidazole and ZnCl2, plus 5 mM ATP, 10 g/ml Uba2/Aos1,
Mitchison, T.J., and Field, C. (1998). Polymerization of purified yeast23 g/ml Ubc9, 23 g/ml SUMO or 45 g/ml reductively methylated
septins: evidence that organized filament arrays may not be requiredSUMO, 0.5 g/ml septins, and 2 g/ml phosphorylated Siz1.
for septin function. J. Cell Biol. 143, 737–749.Lanes 9–14 also lacked BSA.
Hershko, A., and Ciechanover, A. (1998). The ubiquitin system. Annu.
Rev. Biochem. 67, 425–479.Fluorescence Microscopy
Huibregtse, J.M., Scheffner, M., Beaudenon, S., and Howley, P.M.Yeast cells were prepared for indirect immunofluorescence micros-
(1995). A family of proteins structurally and functionally related tocopy essentially as described (Pringle et al., 1991). Cdc11 antibody
the E6-AP ubiquitin-protein ligase. Proc. Natl. Acad. Sci. USA 92,was detected with Cy3-conjugated donkey anti-rabbit IgG (Jackson
2563–2567.Labs). Cells were mounted in 4, 6-diamidino-2-phenylindole (DAPI)-
containing medium to visualize DNA. Cells subjected to DAPI-stain- Joazeiro, C.A., and Weissman, A.M. (2000). RING finger proteins:
ing alone were fixed in cold 70% ethanol rather than formaldehyde. mediators of ubiquitin ligase activity. Cell 102, 549–552.
All micrographs were taken using a 63	 oil objective on a Leica
Johnson, E.S., and Blobel, G. (1997). Ubc9p is the conjugating en-
DM.RXA microscope with a Cool SNAP fx digital camera (Roper
zyme for the ubiquitin-like protein Smt3p. J. Biol. Chem. 272, 26799–
Scientific) and IP Lab software (Scanlytics).
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